Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
Clinical trial NCT05201547 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05201547
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2026-04-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.